Understanding Gleason 8: One of the Most Aggressive Forms of Prostate Cancer

This article was translated from the original Portuguese. Português

Educational Article

Prostate cancer is one of the diseases men fear most around the world, especially when it is discovered at an advanced stage. Among the various grades of aggressiveness of this disease, **Gleason 8** stands out as one of the most feared. To understand what this means and how to deal with this condition, it is essential to know the Gleason scale and the implications of a grade 8 diagnosis.

What Is the Gleason Scale?

Developed in 1966 by the American pathologist Dr. Donald Gleason, this scale is used to assess the aggressiveness of prostate cancer based on the appearance of the cancer cells in a biopsy. The scale ranges from 2 to 10, and the higher the number, the more aggressive the cancer.

In the case of **Gleason 8**, the cancer already shows significant features of aggressiveness, with cells that differ markedly from normal prostate tissue. This means there is a high risk of the tumor spreading to other organs (metastasis) and a lower chance of complete cure.

Diagnosis and Assessment

Diagnosis of prostate cancer usually begins with routine tests such as PSA (prostate-specific antigen) and the digital rectal exam. If there is suspicion, the urologist will order a biopsy, which is the only definitive way to diagnose cancer. During the biopsy, small samples of the prostate are taken and analyzed under the microscope to determine how aggressive the cancer is.

For Gleason 8, the pathologist identifies the two main areas in the cancerous tissue and grades them. For example, a 4+4 pattern indicates that the cells in both areas look very little like normal prostate tissue, which signals a highly aggressive cancer.

Treatment Strategies

Once the diagnosis is confirmed, it is essential to determine whether the cancer is confined to the prostate or has already spread to other organs. This is done with tests such as MRI, bone scan or PET-CT. If the cancer is confined to the prostate, treatment options include surgery to remove the prostate or radiotherapy.

For patients with Gleason 8, robotic surgery has proven to be one of the best options. This technique allows precise removal of the tumor with a lower risk of damage to the nerves that control erection and urinary continence. Radiotherapy is also a viable alternative, especially for those who cannot undergo surgery, although it is often combined with testosterone blockers for greater effectiveness.

Advances in Medicine: Artificial Intelligence

Advances in medicine have brought new tools to help diagnose and treat prostate cancer. One example is the use of Artificial Intelligence (AI) to analyze biopsies. In the United States, the Artera program can already identify areas of greater aggressiveness in cancerous tissue, helping to predict patients' prognosis more accurately.

Final Considerations

Gleason 8 prostate cancer is a serious condition, but with advances in medical technology and appropriate treatment, the chances of control and even cure increase considerably. It is essential for patients to be well informed and in constant dialogue with their physician to choose the best treatment strategy.

To learn more about how prostate cancer is treated and the most modern options available, contact our team. We are ready to help you make the best decisions for your health.

Keywords

#ProstateCancer #Gleason8 #CancerTreatment #MensHealth #RoboticSurgery #ArtificialIntelligence #UrologicOncology #Radiotherapy #arteraai #artera #uroonco #urologist #oncologist

---

🔸 Contact: ☎ (11) 2769-3929 📱 (11) 99590-1506 | WhatsApp: 📲 [Direct link](https://bit.ly/2OIObBx)

💻 [www.clinicauroonco.com.br](https://www.clinicauroonco.com.br) | [Book your appointment](http://bit.ly/2WMMiCI)

📍 R. Borges Lagoa 1070, Cj 52, Vila Mariana - São Paulo - SP

We specialize in uro-oncology and robotic surgery, caring for patients from all over Brazil. Contact our team through the website, by phone or on WhatsApp to book an in-person or telemedicine consultation.

Consider becoming a member of our YouTube channel. We hold a weekly live session to answer questions about prostate cancer, plus exclusive content for members. [Click here to become a member](https://bit.ly/YouTube_Membro_Exclusivo).

Dr. Bruno Benigno | Urologist | CRM SP 126265 | RQE 60022

Clínica Uro Onco Team - São Paulo - SP

Dr. Bruno Benigno
Urologist and uro-oncologic surgeon (CRM-SP 126.265 · RQE 60022). More than 1,500 robotic surgeries. Member of the AUA, EAU and SBU. Meet Dr. Bruno · In the Media

This content is educational and does not replace a medical consultation. Each case must be assessed individually, based on AUA, EAU and NCCN guidelines.